Patent · US Expired

2-acylaminobenzimidazole derivatives for treating glaucoma

US6660870B1 · kind B1 · utility

27Cited by
10References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 10, 2002
Grant dateDec 9, 2003
Priority date—
Expiry dateSep 10, 2022

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/06
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

2-Acylaminobenzimidazole deviates useful for treating glaucoma are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.